These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 84428)

  • 1. The binding of a potent synthetic androgen--methyltrienolone (R 1881)--to cytosol preparations of human prostatic cancer.
    Walsh PC; Greco JM; Tananis CE; Hicks LL; McLoughlin MG; Menon M
    Trans Am Assoc Genitourin Surg; 1977; 69():78-80. PubMed ID: 84428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the binding of a potent synthetic androgen, methyltrienolone, to human tissues.
    Menon M; Tananis CE; Hicks LL; Hawkins EF; McLoughlin MG; Walsh PC
    J Clin Invest; 1978 Jan; 61(1):150-62. PubMed ID: 73547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary report on the measurement of cytosolic and nuclear prostatic tissue steroid receptors.
    Olsson CA; deVere White R; Goldstein I; Traish AM; Müller RE; Wotiz HH
    Prog Clin Biol Res; 1979; 33():209-21. PubMed ID: 93750
    [No Abstract]   [Full Text] [Related]  

  • 4. Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors.
    Barrack ER; Bujnovszky P; Walsh PC
    Cancer Res; 1983 Mar; 43(3):1107-16. PubMed ID: 6186370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytoplasmic androgen receptors in biopsy specimens of prostatic tumors].
    Kushlinskiĭ NE; Degtiar' VG; Bassalyk LS
    Lab Delo; 1983; (7):18-20. PubMed ID: 6194344
    [No Abstract]   [Full Text] [Related]  

  • 6. Androgen receptor assays in advanced prostatic cancer.
    Buttyan R; Olsson CA
    Urol Clin North Am; 1984 May; 11(2):311-7. PubMed ID: 6375068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of natural and synthetic ligands for determining androgen receptors in prostatic tumors and prostatic nodular hyperplasia].
    Kushlinskiĭ NR; Bassalyk LS; Degtiar' VG
    Med Radiol (Mosk); 1983 Aug; 28(8):13-6. PubMed ID: 6193390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of androgen receptor in cytosol of human prostatic tissues with a sepharose-linked antibody system.
    Kliman B; MacLaughlin RA; Prout GR
    Prog Clin Biol Res; 1979; 33():85-96. PubMed ID: 93753
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation between clinical response to hormone therapy and steroid receptor content in prostatic cancer.
    Gustafsson JA; Ekman P; Snochowski M; Zetterberg A; Pousette A; Högberg B
    Cancer Res; 1978 Nov; 38(11 Pt 2):4345-8. PubMed ID: 698975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Importance of determining steroid hormone receptors and the treatment of prostatic cancer].
    Fedotov IA; Denisov LE; Kozlov VP; Degtiar' VG
    Urol Nefrol (Mosk); 1983; (1):63-70. PubMed ID: 6187115
    [No Abstract]   [Full Text] [Related]  

  • 11. Steroid hormone receptors and endocrine response of prostatic carcinoma.
    Jasper WS; Abou-Issa H; Gogate SA; Snider GB
    Cancer Detect Prev; 1987; 10(5-6):393-9. PubMed ID: 2436783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prostatic cytoplasmic androgen receptor in prostatic disease. II. Correlation between clinical response to hormonal therapy and change of R1881 receptor content in prostatic cancer during antiandrogenic therapy].
    Kitano T
    Nihon Hinyokika Gakkai Zasshi; 1984 Jul; 75(7):1098-108. PubMed ID: 6334193
    [No Abstract]   [Full Text] [Related]  

  • 13. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
    Trachtenberg J; Hicks LL; Walsh PC
    J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for the determination of androgen receptor content in human prostatic tissue.
    Trachtenberg J; Hicks LL; Walsh PC
    Invest Urol; 1981 Mar; 18(5):349-54. PubMed ID: 7203958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human prostate steroid hormone receptor quantitation. Current methodology and possible utility as a clinical discriminant in carcinoma.
    Shain SA; Boesel RW
    Invest Urol; 1978 Nov; 16(3):169-74. PubMed ID: 361632
    [No Abstract]   [Full Text] [Related]  

  • 16. Androgen receptor assay in small biopsies of human prostate. Preservation of nuclear receptor from rat ventral prostate by lyophilization.
    de Larminat MA; Scorticati C; Rennie PS; Bruchovsky N
    Prog Clin Biol Res; 1984; 142():247-59. PubMed ID: 6200889
    [No Abstract]   [Full Text] [Related]  

  • 17. Prediction of tumor response to endocrine therapy in prostatic carcinoma based on steroid receptor assay.
    Ekman P; Gustafsson JA; Högberg B; Pousette A; Snochowski M
    Scand J Urol Nephrol Suppl; 1980; 55():83-9. PubMed ID: 6938041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some current problems relating to androgen receptor methodology.
    Geller J; Albert J
    Prog Clin Biol Res; 1979; 33():97-102. PubMed ID: 93754
    [No Abstract]   [Full Text] [Related]  

  • 19. A microassay for the measurement of androgen receptors in human prostatic tissue.
    Hicks LL; Walsh PC
    Steroids; 1979 Apr; 33(4):389-406. PubMed ID: 442131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormonal receptors and other procedures for predicting clinical response in cancer of the prostate].
    Habib FK; Chisholm GD
    Arch Esp Urol; 1984 Dec; 37 Suppl 2():751-9. PubMed ID: 6085672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.